Plain-English translation of NCT03218345 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Neoplasms research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a procedure called EUS-guided radiofrequency ablation (RFA) for treating pancreatic tumors. The procedure uses a thin needle passed through the stomach to deliver controlled heat that destroys tumor tissue. This treatment is designed for people with pancreatic tumors who are unable to undergo traditional surgery.
Surgery is the standard treatment for pancreatic tumors, but many patients cannot have surgery due to age, other serious health conditions, or poor overall health. This trial is exploring whether this minimally invasive heat treatment can offer patients a safe and effective alternative when surgery is not an option.
You likely qualify if…
You likely don't qualify if…
You would receive the radiofrequency ablation procedure, which involves passing a thin needle electrode through an endoscope (a camera tube) down your throat and stomach to reach the pancreatic tumor. The needle delivers controlled heat to destroy the tumor tissue. After the procedure, you would be followed up with imaging and blood tests at regular intervals to monitor how well the treatment worked and check for any side effects.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Hong Kong
Sponsor
Chinese University of Hong Kong
Enrollment target
~30 participants
Started
August 2016
Primary completion
May 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Anthony YB Teoh, Professor
Chinese University of Hong Kong
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.